FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death